Anavex Life Sciences Corp (AVXL)

[Investor2014]

Nor did the AVATAR endpoint ever officially, as in on clinicaltrials.gov.

Well, as far as we can tell, the EXCELLENCE trial's endpoints have never officially changed from the beginning of the trial through to its recent conclusion.

Missling changed the readout to use AUC instead of the protocol EOT because it looked better, but blamed the CRO for being tardy with the clinicaltrials.gov updates.

I am disappointed with the lack of objective due diligence here.